Navamedic ASA (NAVA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10151
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.

Navamedic ASA (NAVA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navamedic ASA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Navamedic Enters into Agreement with bene-Arzneimittel 12
Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13
Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14
Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16
Navamedic Enters Into Distribution Agreement With Torrent Pharma 17
Navamedic Amends Distribution Agreement With Aspen Pharma 18
Equity Offering 19
Navamedic Raises USD1.3 Million in Private Placement of Shares 19
Navamedic ASA – Key Competitors 20
Navamedic ASA – Key Employees 21
Navamedic ASA – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 24, 2018: Navamedic: Q2 2018 results 23
May 30, 2018: Navamedic Announces Q1 2018 results 24
Feb 15, 2018: Navamedic: Q4 2017 Results 25
Nov 10, 2017: Navamedic: Q3 2017 results 26
Jul 28, 2017: Navamedic ASA: Second quarter results 2017 27
Jul 28, 2017: Navamedic: Second quarter results 2017 28
May 10, 2017: Navamedic: Q1 2017 Results 29
Feb 15, 2017: Navamedic: Q4 2016 results 30
Corporate Communications 31
Oct 01, 2018: Navamedic announce Tom Ronnlund to step down as CEO 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Navamedic ASA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Navamedic Enters into Agreement with bene-Arzneimittel 12
Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13
Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14
Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16
Navamedic Enters Into Distribution Agreement With Torrent Pharma 17
Navamedic Amends Distribution Agreement With Aspen Pharma 18
Navamedic Raises USD1.3 Million in Private Placement of Shares 19
Navamedic ASA, Key Competitors 20
Navamedic ASA, Key Employees 21
Navamedic ASA, Subsidiaries 22

List of Figures
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Navamedic ASA (NAVA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Naim Holdings Berhad:企業の戦略・SWOT・財務情報
    Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ratnamani Metals and Tubes Ltd:企業の戦略・SWOT・財務情報
    Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report Summary Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Corium International Inc (CORI):企業の財務・戦略的SWOT分析
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Grupo Juste SAQF-製薬・医療分野:企業M&A・提携分析
    Summary Grupo Juste SAQF (Juste) discovers, develops and distributes pharmaceutical products and active pharmaceutical ingredients (APIs). It develops and manufactures oral and injectable radiological contrast media; antidepressants, oral contraceptives, prebiotic formulations for the prevention of …
  • Yoshinoya Holdings Co Ltd
    Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Pan Orient Energy Corp (POE):石油・ガス:M&Aディール及び事業提携情報
    Summary Pan Orient Energy Corp (POE) is an independent upstream oil and gas company. The company has interests in onshore oil and gas assets in Thailand and Indonesia. It also has interests in Andora Energy Corporation, which holds properties in Northern Alberta. Its assets in Thailand include Conce …
  • PTT Public Company Limited:企業の戦略・SWOT・財務情報
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hafslund ASA:企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Orkla ASA:企業の戦略・SWOT・財務情報
    Orkla ASA - Strategy, SWOT and Corporate Finance Report Summary Orkla ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Electricity Supply Board:企業の発電所・SWOT分析2018
    Electricity Supply Board - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Spherix Inc (SPEX):企業の財務・戦略的SWOT分析
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • Euronav NV (EURN):企業の財務・戦略的SWOT分析
    Summary Euronav NV (Euronav) is a transportation and logistics company that offers shipping services. The company provides sea-borne transportation, tanker shipping, proactive management, fleet composition and ship management services, among others. It offers ship management services which includes …
  • Genesis Energy LP (GEL):企業の財務・戦略的SWOT分析
    Genesis Energy LP (GEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Solar Frontier KK:電力:M&Aディール及び事業提携情報
    Summary Solar Frontier KK (Solar Frontier), a subsidiary of Showa Shell Sekiyu K.K. is a renewable energy company that offers solar energy equipment. The company develops and manufacturers copper, indium and selenium thin film photovoltaic modules. It develops power plant projects and manages power …
  • Cimarex Energy Co (XEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Cimarex Energy Co (Cimarax) is an independent upstream oil and natural gas company. It carries out the exploration and production of crude oil, natural gas and natural gas liquids (NGLs). The company’s operations are concentrated in two main areas namely the Mid-Continent region consisting o …
  • Odakyu Electric Railway Co., Ltd. (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co., Ltd. (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆